NCT03470428

Brief Summary

This study aims to determine what are some of the clinical characteristics and associations of Fontan patients who are doing well, as well as how accurate cardiology providers are at predicting the likelihood of future adverse event in their Fontan patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
146

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 5, 2018

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

March 6, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 20, 2018

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2023

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 18, 2023

Completed
Last Updated

April 19, 2023

Status Verified

April 1, 2023

Enrollment Period

5 years

First QC Date

March 6, 2018

Last Update Submit

April 18, 2023

Conditions

Keywords

FontanSingle Ventricle

Outcome Measures

Primary Outcomes (1)

  • Surprise question

    The ability of the cardiologist's response to the "surprise" question to predict adverse cardiac events within 1 year

    1 year

Secondary Outcomes (3)

  • Clinical characteristics and associations of the "good Fontan"

    1 year

  • Correlation between patient and provider assessments

    1 year

  • Clinician factors associated with adverse events conversation with patients

    1 year

Study Arms (2)

Pediatric Fontan Patients

Participants ages 10 to 18 who have had Lateral Tunnel or Extracardiac Fontan procedures.

Adult Fontan Patients

Participants ages 18 to 60 who have had Lateral Tunnel or Extracardiac Fontan procedures.

Eligibility Criteria

Age10 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients with congenital heart disease who have undergone the Fontan procedure.

You may qualify if:

  • Extracardiac or Lateral Funnel Fontan

You may not qualify if:

  • Currently being evaluated for or listed for cardiac transplant
  • Underwent Fontan revision or conversion
  • Currently pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Children's Hospital

Boston, Massachusetts, 02115, United States

Location

Related Publications (5)

  • d'Udekem Y, Iyengar AJ, Cochrane AD, Grigg LE, Ramsay JM, Wheaton GR, Penny DJ, Brizard CP. The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation. 2007 Sep 11;116(11 Suppl):I157-64. doi: 10.1161/CIRCULATIONAHA.106.676445.

    PMID: 17846297BACKGROUND
  • Diller GP, Giardini A, Dimopoulos K, Gargiulo G, Muller J, Derrick G, Giannakoulas G, Khambadkone S, Lammers AE, Picchio FM, Gatzoulis MA, Hager A. Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients. Eur Heart J. 2010 Dec;31(24):3073-83. doi: 10.1093/eurheartj/ehq356. Epub 2010 Oct 7.

    PMID: 20929979BACKGROUND
  • Blume ED, Balkin EM, Aiyagari R, Ziniel S, Beke DM, Thiagarajan R, Taylor L, Kulik T, Pituch K, Wolfe J. Parental perspectives on suffering and quality of life at end-of-life in children with advanced heart disease: an exploratory study*. Pediatr Crit Care Med. 2014 May;15(4):336-42. doi: 10.1097/PCC.0000000000000072.

    PMID: 24583501BACKGROUND
  • Lakin JR, Robinson MG, Bernacki RE, Powers BW, Block SD, Cunningham R, Obermeyer Z. Estimating 1-Year Mortality for High-Risk Primary Care Patients Using the "Surprise" Question. JAMA Intern Med. 2016 Dec 1;176(12):1863-1865. doi: 10.1001/jamainternmed.2016.5928. No abstract available.

    PMID: 27695853BACKGROUND
  • Hamano J, Morita T, Inoue S, Ikenaga M, Matsumoto Y, Sekine R, Yamaguchi T, Hirohashi T, Tajima T, Tatara R, Watanabe H, Otani H, Takigawa C, Matsuda Y, Nagaoka H, Mori M, Yamamoto N, Shimizu M, Sasara T, Kinoshita H. Surprise Questions for Survival Prediction in Patients With Advanced Cancer: A Multicenter Prospective Cohort Study. Oncologist. 2015 Jul;20(7):839-44. doi: 10.1634/theoncologist.2015-0015. Epub 2015 Jun 8.

    PMID: 26054631BACKGROUND

MeSH Terms

Conditions

Heart Defects, CongenitalUniventricular Heart

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Rahul Rathod, MD

    Boston Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Cardiologist

Study Record Dates

First Submitted

March 6, 2018

First Posted

March 20, 2018

Study Start

March 5, 2018

Primary Completion

March 20, 2023

Study Completion

April 18, 2023

Last Updated

April 19, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations